Large-scale testing (Phase 3)Study completedNCT00451217
What this trial is testing
Comparison of Sugammadex (Org 25969) With Neostigmine as Reversal Agents for Rocuronium or Vecuronium at Reappearance of T2 (P05960)
Who this might be right for
Anesthesia, General
Merck Sharp & Dohme LLC 198